Bellicum Pharmaceuticals

Sirtris Pharmaceuticals

Sirtris Pharmaceuticals is a biopharmaceutical company developing and commercializing novel therapeutics that modulate sirtuins, a recently discovered family of enzymes that promotes the body's natural defense against disease. Acquired by GlaxoSmithKline in 2008.

Select Venture Capital & Financial Partners

Alexandria Real Estate Equities Bessemer Venture Partners Cardinal Partners Cargill Ventures Cycad Group Genzyme Hunt Ventures, L.P. Novartis Venture Fund Polaris Venture Partners QTV Capital Red Abbey Venture Partners Skyline Ventures Three Arch Partners TVM Wellcome Trust